Key result
Genetically engineered mouse models harboring human gene mutations have provided critical insights into the mechanisms underlying channelopathies, conduction disorders, and cardiomyopathies.
Genetically engineered mice are essential mammalian models for elucidating the molecular mechanisms of inherited arrhythmogenic diseases and sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Mouse models extend mechanistic research on inherited arrhythmias; leaves open clinical translation without human validation.
Sudden cardiac death due to ventricular tachyarrhythmias remains an unresolved problem, probably because the mechanisms responsible for the progression of cardiac disease to electrophysiological failure are poorly understood. Genetically engineered mice, the principal mammalian model for studying cardiac electrophysiology, have contributed to the understanding of the genetic, molecular and systemic mechanisms involved in the initiation and/or maintenance of cardiac arrhythmias leading to cardiac death, e.g. cardiac excitability, conduction velocity and refractoriness. Several murine models harbouring human gene mutations leading to electrical and structural cardiac disorders have been developed, including channelopathies (long QT syndrome), familial conduction disorders, cardiomyopathies and other inherited cardiac disorders. This article reviews the results of the main genetically modified mice addressing the genesis of cardiac arrhythmias and sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Juan Tamargo (2006) conducted a review in Cardiac arrhythmias and sudden cardiac death. Genetically engineered mice models was evaluated. Genetically engineered mouse models harboring human gene mutations have provided critical insights into the mechanisms underlying channelopathies, conduction disorders, and cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: